$NAII News

Natural Alternatives Q4 Loss Widens Y/Y on Margin Pressure

Natural Alternatives International, Inc. Announces Fiscal 2026 Q4 and YTD Results

Update: Natural Alternatives Intl Q4 Adj. EPS $(0.52) Up From $(1.20) YoY, Sales $34.508M Up From $33.866M YoY

Natural Alternatives Intl Q4 EPS $(2.23) Down From $(1.20) YoY, Sales $34.508M Up From $33.866M YoY

Natural Alternatives International Says Initiated A Comprehensive Review Process To Explore Strategic Alternatives; Initiated Consolidation Of Our USA Manufacturing Operations Into Our Vista, CA Facility

Natural Alternatives Q3 Loss Widens Y/Y on Margin Pressure

Natural Alternatives International, Inc. Announces 2026 Q3 and YTD Results

Natural Alternatives Intl Q3 EPS $(0.72) Down From $(0.37) YoY, Sales $35.482M Up From $28.766M YoY

CarnoSyn® Brands Expands TriBsyn® Applications Across Beverage, Dairy, and Medical Nutrition

Natural Alternatives International Michael E. Fortin Resigns As CFO Effective May 15, 2026; Kenneth E. Wolf To Act As Principal Financial And Accounting Officer During CFO Search

Natural Alternatives Q2 Loss Widens Y/Y, Sales Increase

Natural Alternatives: Fiscal Q2 Earnings Snapshot

Natural Alternatives International, Inc. Announces 2026 Q2 and YTD Results

Natural Alternatives Intl Q2 EPS $(0.42) Down From $(0.37) YoY, Sales $34.795M Up From $34.078M YoY

Niche Focus & Regulation Shape the Future of Healthcare Firms

Natural Alternatives International, shares are trading higher after the company reported a year-over-year increase in Q1 financial results

Natural Alternatives International, shares are trading higher after the company reported a year-over-year increase in Q1 financial results

Natural Alternatives: Fiscal Q1 Earnings Snapshot

Natural Alternatives International, Inc. Announces 2026 Q1 Results

Natural Alternatives Intl Q1 EPS $(0.05) Up From $(0.33) YoY, Sales $37.730M Up From $33.150M YoY